About GSK Pharma India Private Limited
Data last updated:
GSK Pharma India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Glaxo Group Limited Uk. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 June 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2000PTC126937. Its GSTIN is 27AAFCS2309Q1ZY (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹12.8 Cr and a paid-up capital of ₹7.68 Cr. It was formerly known as Stiefel India Private Limited. It is led by directors Ayush Kumar and Ajay Avinash Nadkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Battery House Bhulabhai Desai Road, Mumbai, Maharashtra, India – 400026.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.87 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹2.26 Cr (net margin 7.1%) and EBITDA of ₹3.42 Cr (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 4% over five years.
The company is associated with 1 brand: Stiefel. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stiefel.co.in.
Company details
Contact details
GSK Pharma India Private Limited's registered office is in Mumbai, Maharashtra. Its website is stiefel.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1 Battery House Bhulabhai Desai Road, Mumbai, Maharashtra, India – 400026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of GSK Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
GSK Pharma India operates one associated brand: Stiefel. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Dermatology prescription products are manufactured and marketed globally. | stiefel.com |
Business activity
The main business activity of GSK Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of GSK Pharma India Private Limited, buy the company report.
Financials of GSK Pharma India Private Limited
FY 2025 filings availableGSK Pharma India Private Limited reported revenue of ₹31.87 Cr (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 49% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.42 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.7% | ||||
| Net Profit Margin | 7.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GSK Pharma India Private Limited, buy the company report.
Board of directors of GSK Pharma India Private Limited
GSK Pharma India has 2 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayush Kumar | Director | 15 Jan 2024 | 2 Years 9 Months | Current |
| Ajay Avinash Nadkarni Also directs: Biddle Sawyer Limited, GSK India Global Services Private Limited | Director | 03 Jan 2011 | 15 Years 9 Months | Current |
Peer comparison
GSK Pharma India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Exim Distributors Private Limited | ₹32.33 Cr (FY 2025) | -17.0% | Kolkata, West Bengal, India | |||
| Shubh Medicorp (India) Private Limited | ₹32.12 Cr (FY 2024) | -24.0% | Pune, Maharashtra, India | |||
| GSK Pharma India Private Limitedthis company | ₹31.87 Cr (FY 2025) | ₹2.26 Cr | 7.1% | 49.0% | Mumbai, Maharashtra, India | |
| Nirvvan Lifescience Private Limited | ₹31.76 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Arlak Biotech Private Limited | ₹31.65 Cr (FY 2025) | 22.0% | Zirakpur, Punjab, India | |||
| Rare Metabolics Life-Sciences Private Limited | ₹31.63 Cr (FY 2024) | 443.0% | New Delhi, Delhi, India | |||
| Rusan Health Care Private Limited | ₹31.6 Cr (FY 2024) | 4.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of GSK Pharma India Private Limited, buy the company report.
Auditor
GSK Pharma India Private Limited is audited by M. P. Chitale & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. P. Chitale & Co. | FY 2023 | 101851W |
Shareholding
The shareholding of GSK Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of GSK Pharma India Private Limited, buy the company report.
Legal cases
GSK Pharma India Private Limited has 1 court case on record: 1 filed by GSK Pharma India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Municipal Corpn. of GR. Mumbai and 3 Ors. | Disposed |
To see the full case history of GSK Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GSK Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
GSK Pharma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCS2309Q1ZY | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of GSK Pharma India Private Limited, buy the company report.
Recent activity
GSK Pharma India Private Limited has 16 board changes on record since 2007: 2 appointments and 14 cessations. The latest: Ayush Kumar ceased to be Additional Director on 24 Sep 2024.
7 earlier events are in the company report.
News
Frequently asked questions
GSK Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 June 2000 (26+ years old) and is registered under CIN U24239MH2000PTC126937.
GSK Pharma India has 2 current directors:
- Ayush Kumar - Director
- Ajay Avinash Nadkarni - Director
The latest financial statements of GSK Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of GSK Pharma India is 27AAFCS2309Q1ZY, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of GSK Pharma India is U24239MH2000PTC126937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GSK Pharma India has 1 court case on record: 1 filed by the company.
GSK Pharma India was incorporated on 02 June 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of GSK Pharma India by revenue are Exim Distributors Private Limited, Shubh Medicorp (India) Private Limited, Nirvvan Lifescience Private Limited, Arlak Biotech Private Limited, Rare Metabolics Life-Sciences Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ayush Kumar ceased to be Additional Director on 24 Sep 2024. Ayush Kumar was appointed as Director on 15 Jan 2024. Nina Kailas Wagle ceased to be Company Secretary on 30 Apr 2023. GSK Pharma India has 16 board changes on record in total.
GSK Pharma India can be reached through the website stiefel.co.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of GSK Pharma India is at 1 Battery House Bhulabhai Desai Road, Mumbai, Maharashtra, India – 400026.